Results 91 to 100 of about 9,727 (224)
Haemosiderin-laden sputum macrophages for diagnosis in pulmonary veno-occlusive disease. [PDF]
PLoS ONE, 2014 Pulmonary veno-occlusive disease (PVOD) is a rare condition of pulmonary arterial hypertension (PAH), in which post-capillary veins are affected. Since the therapeutic approach in PVOD differs from other forms of PAH, it is crucial to establish the ...
Heidi Lederer +8 more
doaj +1 more source
European Journal of Heart Failure, Volume 27, Issue 11, Page 2152-2167, November 2025.Specific characteristics of HFpEF universal definition in cancer patients. Abstract Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized in cancer patients and survivors, yet it remains underdiagnosed and its epidemiology largely unknown.
Kalliopi Keramida +21 more
wiley +1 more source
DIAGNOSTIC SPECIFICS OF PULMONARY VENO-OCCLUSIVE DISEASE
Российский кардиологический журнал, 2012 The authors present the two-year follow-up of a female patient with severe pulmonary hypertension and a rare pathology – pulmonary veno-occlusive disease. Due to the treatment with low-dose prednisolone, in combination with warfarin, coraxan, and oxygen,
E. A. Zhuk +4 more
doaj
Cancer Medicine, Volume 14, Issue 19, October 2025.ABSTRACT Introduction For pediatric patients with solid tumors, the use of growth factors following chemotherapy evolved from daily filgrastim to pegylated filgrastim. Currently, post‐chemotherapy laboratory work is obtained to monitor for transfusion needs rather than count recovery.
Catherine B. Wall +3 more
wiley +1 more source
Pulmonary veno-occlusive disease
Revue des maladies respiratoires, 2018 Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension (PH) characterized by preferential remodelling of pulmonary venules and angioproliferation. PVOD term includes idiopathic, heritable (biallelic mutations of EIF2AK4 gene), drugs and toxins induced (alkylating agents, organic solvents) and connectivite-associated forms ...
A, Boucly +11 more
openaire +3 more sources
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
European Respiratory Review, 2009 A 27-yr-old female with a 6-month diagnosis of idiopathic pulmonary arterial hypertension (PAH) confirmed elsewhere was referred to our centre with worsening dyspnoea.
M. Palazzini, A. Manes
doaj
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia [PDF]
, 2019 The majority of adult patients affected by B-cell acute lymphoblastic leukemia (B-ALL) will relapse after an initial response, while approximately 20% will display primary resistant disease. Patients suffering from relapsed/refractory B-ALL have a very
Lanza, Francesco +2 more
core +1 more source
VV‐ECMO for TRALI/TACO During Treatment of Hemorrhagic Gastric Ulcer: A Case Report
Clinical Case Reports, Volume 13, Issue 10, October 2025.ABSTRACT A 77‐year‐old man with no medical history was admitted with hematemesis. Vital signs indicated shock, and massive amounts of allogeneic blood were transfused. His respiratory condition deteriorated, and veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) was initiated. He was weaned from VV‐ECMO and transferred to another hospital on Day
Mayu Shindo +3 more
wiley +1 more source
Lung Biopsy in Pulmonary Veno-Occlusive Disease [PDF]
, 2001 Ivan M. Robbins +2 more
openalex +3 more sources
Principles of pharmacological correction of pulmonary arterial hypertension [PDF]
, 2018 Prostanoids are a promising group of drugs for the treatment of pulmonary arterial hypertension (PAH), since they possess not only vasodilating, but also antiplatelet and antiproliferative actions.
Korokin, M. V. +3 more
core +2 more sources